You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

binimetinib

Showing 1 - 25 of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Solid Tumor Trial in Toronto (Binimetinib, Encorafenib)

Recruiting
  • Solid Tumor
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 23, 2022

Metastatic Uveal Melanoma Trial in Tampa (Binimetinib, Belinostat)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • Binimetinib
  • (no location specified)
Aug 18, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Binimetinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Melanoma Trial in Worldwide (encorafenib, binimetinib, pembrolizumab)

Recruiting
  • Melanoma
  • Siena, Toscana, Italy
  • +11 more
Jun 23, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • Binimetinib
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • Binimetinib
  • +6 more
  • (no location specified)
Nov 8, 2022

BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

Recruiting
  • BRAF NP_004324.2:p.V600M
  • +6 more
  • Binimetinib
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Aug 17, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Binimetinib
  • +5 more
  • (no location specified)
Nov 8, 2022

Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

Recruiting
  • Colorectal Carcinoma
  • +3 more
  • Binimetinib
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 11, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Binimetinib
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • Binimetinib
  • +3 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Gastrointestinal Stromal Tumors Trial (Ripretinib, binimetinib)

Withdrawn
  • Gastrointestinal Stromal Tumors
  • (no location specified)
Dec 15, 2021

Melanoma Trial in Pittsburgh (encorafenib, nivolumab, ipilimumab)

Recruiting
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Mar 24, 2022

Lung Cancer Trial in Boston (Binimetinib, Palbociclib)

Recruiting
  • Lung Cancer
  • Boston, Massachusetts
  • +1 more
Jan 18, 2022

Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Breast Adenocarcinoma
  • +6 more
  • Binimetinib
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 14, 2021

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Advanced NSCLC, KRAS Gene Mutation, Lung Cancer Trial in Switzerland (Binimetinib, Pemetrexed, Cisplatin)

Completed
  • Advanced Non-small Cell Lung Cancer
  • +2 more
  • Binimetinib
  • +2 more
  • Basel, Switzerland
  • +3 more
Jul 13, 2021

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • Binimetinib
  • +10 more
  • (no location specified)
Nov 8, 2022

Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab

Recruiting
  • Malignant Melanoma
  • Pembrolizumab Injection [Keytruda]
  • +6 more
  • Herlev, Hovedstaden, Denmark
  • +2 more
Sep 16, 2022

Metastatic Melanoma, Brain Metastases Trial in Spain (encorafenib, binimetinib, Whole brain radiation therapy)

Recruiting
  • Metastatic Melanoma
  • Brain Metastases
  • Palma De Mallorca, Baleares, Spain
  • +20 more
Feb 16, 2022

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

NSCLC Trial in China, Taiwan (Encorafenib, Binimetinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Beijing, China
  • +35 more
Jun 29, 2022